D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 23,407 251 World Ranking 15631 National Ranking 735

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Endocrinology

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin, Gastric inhibitory polypeptide and Incretin. Internal medicine is often connected to Gastroenterology in his work. His research related to Glucagon-like peptide-1, Glucagon, Diabetes mellitus, Gastrointestinal hormone and Peptide hormone might be considered part of Endocrinology.

His study in Stimulation extends to Insulin with its themes. His work deals with themes such as Ingestion, Carbohydrate metabolism and Endogeny, which intersect with Gastric inhibitory polypeptide. His Incretin research incorporates themes from Hormone, Antiserum and Glucose clamp technique.

His most cited work include:

  • Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. (1309 citations)
  • Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. (1052 citations)
  • Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. (944 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Endocrinology, Insulin, Gastric inhibitory polypeptide and Gastroenterology. His research brings together the fields of Diabetes mellitus and Internal medicine. While the research belongs to areas of Endocrinology, Werner Creutzfeldt spends his time largely on the problem of Cholecystokinin, intersecting his research to questions surrounding Secretin and Antagonist.

His Insulin study frequently draws connections between adjacent fields such as Ingestion. The Gastric inhibitory polypeptide study combines topics in areas such as Postprandial, Endogeny and Secretion. His Gastroenterology research includes themes of Disease and Endocrine system.

He most often published in these fields:

  • Internal medicine (79.31%)
  • Endocrinology (68.97%)
  • Insulin (32.07%)

What were the highlights of his more recent work (between 1991-2009)?

  • Internal medicine (79.31%)
  • Endocrinology (68.97%)
  • Insulin (32.07%)

In recent papers he was focusing on the following fields of study:

Werner Creutzfeldt mainly focuses on Internal medicine, Endocrinology, Insulin, Gastroenterology and Glucagon-like peptide-1. His Pancreatic disease, Pancreatitis, Pancreas, Gastric acid and Peptide hormone study are his primary interests in Internal medicine. His work investigates the relationship between Endocrinology and topics such as Cholecystokinin that intersect with problems in Secretagogue.

The study incorporates disciplines such as Carcinoma, Disease, Gastrin and Endocrine system in addition to Gastroenterology. His study in Glucagon-like peptide-1 is interdisciplinary in nature, drawing from both Metformin, Gastric emptying, Acarbose and Hormone, Glucagon. His Incretin research is multidisciplinary, incorporating perspectives in Pharmacology and Renal function.

Between 1991 and 2009, his most popular works were:

  • Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. (1309 citations)
  • Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. (944 citations)
  • Early ERCP and Papillotomy Compared with Conservative Treatment for Acute Biliary Pancreatitis (512 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Diabetes mellitus

His scientific interests lie mostly in Internal medicine, Endocrinology, Glucagon-like peptide-1, Glucagon and Insulin. His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with issues in Endocrine system. Diabetes mellitus, Gastric inhibitory polypeptide, Gastrointestinal hormone, Peptide hormone and Gastric acid are among the areas of Endocrinology where Werner Creutzfeldt concentrates his study.

His work in Glucagon-like peptide-1 addresses issues such as Hormone, which are connected to fields such as Receptor, Appetite, Pharmacology, Islet and Enterogastrone. His biological study spans a wide range of topics, including Acarbose and Gastric emptying. His study in Pancreatic hormone, Incretin and Glucagon secretion falls under the purview of Insulin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

M A Nauck;M M Heimesaat;C Orskov;J J Holst.
Journal of Clinical Investigation (1993)

1727 Citations

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.

M. Nauck;F. Stöckmann;R. Ebert;W. Creutzfeldt.
Diabetologia (1986)

1676 Citations

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

M. A. Nauck;N. Kleine;C. Orskov;J. J. Holst.
Diabetologia (1993)

1282 Citations

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

M A Nauck;E Homberger;E G Siegel;R C Allen.
The Journal of Clinical Endocrinology and Metabolism (1986)

1011 Citations

The incretin concept today.

W. Creutzfeldt.
Diabetologia (1979)

990 Citations

Early ERCP and Papillotomy Compared with Conservative Treatment for Acute Biliary Pancreatitis

Ulrich R. Fölsch;Rolf Nitsche;Rainer Lüdtke;Reinhard A. Hilgers.
The New England Journal of Medicine (1997)

837 Citations

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

B Willms;J Werner;J J Holst;C Orskov.
The Journal of Clinical Endocrinology and Metabolism (1996)

754 Citations

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.

M A Nauck;E Bartels;C Orskov;R Ebert.
The Journal of Clinical Endocrinology and Metabolism (1993)

655 Citations

Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease.

Paul Georg Lankisch;Annette Löhr-Happe;Jutta Otto;Werner Creutzfeldt.
Digestion (1993)

579 Citations

Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I diabetic patients

Werner O C Creutzfeldt;Nicola Kleine;Berend Willms;Cathrine Ørskov.
Diabetes Care (1996)

512 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Werner Creutzfeldt

Jens J. Holst

Jens J. Holst

University of Copenhagen

Publications: 372

Michael Horowitz

Michael Horowitz

University of Adelaide

Publications: 144

Carolyn F. Deacon

Carolyn F. Deacon

University of Copenhagen

Publications: 115

Filip K. Knop

Filip K. Knop

University of Copenhagen

Publications: 110

Peter R. Flatt

Peter R. Flatt

University of Ulster

Publications: 107

Karen L. Jones

Karen L. Jones

University of Adelaide

Publications: 104

Michael A. Nauck

Michael A. Nauck

Ruhr University Bochum

Publications: 90

Bo Ahrén

Bo Ahrén

Lund University

Publications: 88

Sten Madsbad

Sten Madsbad

Copenhagen University Hospital

Publications: 86

Juris J. Meier

Juris J. Meier

Ruhr University Bochum

Publications: 75

Rudolf Arnold

Rudolf Arnold

Philipp University of Marburg

Publications: 66

David A. D'Alessio

David A. D'Alessio

Duke University

Publications: 64

Daniel J. Drucker

Daniel J. Drucker

Lunenfeld-Tanenbaum Research Institute

Publications: 64

Burkhard Göke

Burkhard Göke

Ludwig-Maximilians-Universität München

Publications: 54

Robert T. Jensen

Robert T. Jensen

National Institutes of Health

Publications: 43

Jens F. Rehfeld

Jens F. Rehfeld

University of Copenhagen

Publications: 42

Trending Scientists

Biplav Srivastava

Biplav Srivastava

University of South Carolina

Gerard Kerkyacharian

Gerard Kerkyacharian

Université Paris Cité

Elias Masry

Elias Masry

University of California, San Diego

Shmuel Shaffer

Shmuel Shaffer

Cisco Systems (China)

Dimitris Kiritsis

Dimitris Kiritsis

École Polytechnique Fédérale de Lausanne

Rudolf Jaffé

Rudolf Jaffé

Florida International University

Dennis C. Liotta

Dennis C. Liotta

Emory University

Fabrice Gritti

Fabrice Gritti

Waters (United States)

Massimo Morbidelli

Massimo Morbidelli

Polytechnic University of Milan

Jaap J. Beintema

Jaap J. Beintema

University of Groningen

Norma W. Andrews

Norma W. Andrews

University of Maryland, College Park

Abraham Aseffa

Abraham Aseffa

Armauer Hansen Research Institute

Stephan Ehl

Stephan Ehl

University of Freiburg

Sander Thomaes

Sander Thomaes

Utrecht University

Lewis B. Holmes

Lewis B. Holmes

Harvard University

Something went wrong. Please try again later.